Retrovirology

official impact factor 5.24

Open Access Highly Access Commentary

Towards a genetic AIDS vaccine

Antonia V Bordería and Ben Berkhout*

Author Affiliations

Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infectious Diseases and Immunology Amsterdam (CINIMA), Academic Medical Center (AMC), University of Amsterdam, the Netherlands

For all author emails, please log on.

Retrovirology 2009, 6:93 doi:10.1186/1742-4690-6-93

Published: 16 October 2009

Abstract

We discuss a recent Nature Medicine publication by Philip Johnson and co-workers (Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys. Nat. Med. 2009, 15: 901-906) in which an effective HIV-1 vaccine was designed that is based on gene therapy. The introduced gene produces an antibody-like immunoadhesin in the blood that neutralizes the virus.